CRPGF (China Resources Pharmaceutical Group) EPS (Basic): $0.09 (TTM As of Dec. 2025)


CRPGF China Resources Pharmaceutical Group Ltd CRPGF
89 GF Score
Price $0.56
GF Value $0.74
! 3 Warning Signs
View Full Analysis

What is China Resources Pharmaceutical Group EPS (Basic)?

China Resources Pharmaceutical Group CRPGF 89 EPS (Basic) is $0.09 as of Dec. 2025. GuruFocus rates CRPGF with a GF Score™ of 89/100 and a GF Value™ of $0.74. The stock has 3 warning signs investors should review.

China Resources Pharmaceutical Group's basic earnings per share (Basic EPS) for the six months ended in Dec. 2025 was $0.04. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.09.

China Resources Pharmaceutical Group's EPS (Diluted) for the six months ended in Dec. 2025 was $0.04. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.09.

China Resources Pharmaceutical Group's EPS without NRI for the six months ended in Dec. 2025 was $0.06. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 0.10.

During the past 12 months, China Resources Pharmaceutical Group's average EPS without NRIGrowth Rate was 17.50% per year. During the past 3 years, the average EPS without NRI Growth Rate was 5.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 8.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, China Resources Pharmaceutical Group's highest 3-Year average EPS without NRI Growth Rate was 28.40% per year. The lowest was -13.30% per year. And the median was 8.40% per year.

China Resources Pharmaceutical Group  (OTCPK:CRPGF) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

China Resources Pharmaceutical Group EPS (Basic) Related Terms

China Resources Pharmaceutical Group EPS (Basic) Historical Data

* Premium members only.

The historical data trend for China Resources Pharmaceutical Group's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China Resources Pharmaceutical Group EPS (Basic) Chart

China Resources Pharmaceutical Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.08 0.09 0.07 0.09

China Resources Pharmaceutical Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.06 0.02 0.05 0.04
CRPGF
89GF Score
China Resources Pharmaceutical Group Ltd CRPGF
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Resources Pharmaceutical Group EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

China Resources Pharmaceutical Group's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(574.379-0)/6282.510
=0.09

China Resources Pharmaceutical Group's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(279.445-0)/6282.510
=0.04

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $0.09 mean?
China Resources Pharmaceutical Group (CRPGF) has a EPS (Basic) of $0.09 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on China Resources Pharmaceutical Group and its competitors.
Is China Resources Pharmaceutical Group's EPS (Basic) too high?
China Resources Pharmaceutical Group's current EPS (Basic) is $0.09. Overall, China Resources Pharmaceutical Group has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Pharmaceutical Group's EPS (Basic) compare to ZTS?
China Resources Pharmaceutical Group's EPS (Basic) of $0.09 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on China Resources Pharmaceutical Group and its competitors. China Resources Pharmaceutical Group's current EPS (Basic) is $0.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Pharmaceutical Group stock overvalued right now?
China Resources Pharmaceutical Group (CRPGF) has a current EPS (Basic) of $0.09. The stock's GF Value™ is $0.74, compared to a current price of $0.56 — trading 24.3% below its estimated fair value. The current EPS (Basic) is $0.09. China Resources Pharmaceutical Group's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For China Resources Pharmaceutical Group (CRPGF), the current EPS (Basic) is $0.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Resources Pharmaceutical Group (CRPGF) Overvalued in 2026?

Based on GuruFocus' analysis, China Resources Pharmaceutical Group stock appears to be undervalued. The current stock price of $0.56 is trading 24.3% below its estimated GF Value™ of $0.74.

Key valuation signals for CRPGF:

  • EPS (Basic): $0.09
  • GF Value™: $0.74 vs. price of $0.56 (24.3% below fair value)
  • GF Score™: 89/100 with 3 warning signs

No single metric tells the full story. See the CRPGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

China Resources Pharmaceutical Group Business Description

Other Exchanges 03320:Hong Kong640:Germany
Address 26 Harbour Road, Room 4104-05, 41st Floor, China Resources Building, Wanchai, HKG
China Resources Pharmaceutical Group Ltd is principally engaged in the manufacture, distribution and retail of pharmaceutical and healthcare products. Specifically, the Group has four reportable segments as follows: Pharmaceutical manufacturing business, Pharmaceutical distribution business, Pharmaceutical retail business , and Other business operations. The company generates majority of its revenue from the Pharmaceutical distribution business.
89GF Score

Get the complete analysis for CRPGF

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.56
Price
$0.74
GF Value